Added to YB: 2025-06-04
Pitch date: 2025-06-02
CDIO [bullish]
Cardio Diagnostics Holdings, Inc.
-29.18%
current return
Author Info
Stock Pursuit researches domestic deep value equities below net cash, net current asset value or net tangible assets. Sign up for the newsletter.
Company Info
Cardio Diagnostics Holdings, Inc. develops and commercializes epigenetics-based clinical tests for cardiovascular disease.
Market Cap
$7.0M
Pitch Price
$4.37
Price Target
N/A
Dividend
N/A
EV/EBITDA
0.37
P/E
-0.78
EV/Sales
-97.44
Sector
Biotechnology
Category
growth
Cardio Diagnostics Holdings - $CDIO
CDIO: Epigenetic heart test co. trading at $6.9M mkt cap vs $8.7M net cash, no LT debt. 3 tests (Epi+Gen CHD, Precision CHD, ACI) address $8.5B market. AI-driven tech outperforms traditional tests. Revenue +100% YoY but still tiny ($34.8K). New sales team, 7 new practices signed. Acquisition potential from Quest/LabCorp/Roche.
Read full article (5 min)